Our client, following the advent of the new oral anticoagulants on the market, asked us to come up with a project addressing experience in the use of the new oral anticoagulants (NOACs), defining the different patient profiles and reaching a consensus regarding the advantages of the NOACs over other alternatives.

A total of 39 specialists with extensive experience in anticoagulation took part in 6 regional meetings.

Physicians’ perception of the factors that impact the choice of a dicumarinic or a new oral anticoagulant in patients with nonvalvular atrial fibrillation.